Valbiotis - Combined Annual Shareholders General Meeting held on May 2, 2023

Regulatory News: Valbiotis (FR0013254851 ALVAL, PEA SME eligible), a commercially oriented Research and Development company, committed to scientific innovation for preventing and combating metabolic

Related Keywords

Quebec ,Canada ,France ,Riom ,Auvergne ,French ,Seitosei Actifin ,Espace Encan ,Public Affairs ,European Union ,Innovative Company ,European Regional Development Fund ,Research Development ,Regulatory News ,Combined Annual Shareholders Meeting ,Supervisory Board ,General Meeting ,Shareholder Meeting ,Quebec City ,Valbiotis Universal Registration Document ,French Financial Markets Regulator ,Public Affairs Director ,Valbiotis ,Combined ,Nnual ,Shareholders ,Eneral ,Meeting ,Held ,023 ,